Golden Lee Scott 4
4 · Cadrenal Therapeutics, Inc. · Filed Dec 3, 2025
Insider Transaction Report
Form 4
Golden Lee Scott
Director
Transactions
- Award
Stock Options
2025-12-02+5,000→ 5,000 totalExercise: $8.27From: 2027-01-01Exp: 2035-12-01→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]Consists of options to purchase 5,000 shares of common stock, which shall vest 1/3 on January 1, 2027 and thereafter pro rata on a monthly basis over 24 months, subject to the Reporting Person's continued service to the Issuer through each vesting date, having an exercise price equal to the fair market value of the Issuer's common stock on the effective date of the grant.